Phthalimide neovascular factor 1 (PNF1) modulates MT1-MMP activity in human microvascular endothelial cells

Biotechnology and Bioengineering

Volumn 103, Issue 4, 2009, Pages 796-807

  Wieghaus, Kristen A ^a   Gianchandani, Erwin P ^a   Neal, Rebekah A ^a   Paige, Mikell A ^b   Brown, Milton L ^b   Papin, Jason A ^a   Botchwey, Edward A ^a,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Angiogenesis; Drug discovery; Matrix metalloproteinase; Network analysis; Small molecule; Transcriptional profiling

Indexed keywords

ANGIOGENESIS; DRUG DISCOVERY; MATRIX METALLOPROTEINASE; NETWORK ANALYSIS; SMALL MOLECULE; TRANSCRIPTIONAL PROFILING;

BLOOD VESSEL PROSTHESES; DRUG PRODUCTS; ELECTRIC NETWORK ANALYSIS; ENZYME INHIBITION; GELATION; GLYCOPROTEINS; MATRIX ALGEBRA; MOLECULES; PROBES; SELF ASSEMBLY; SIGNALING; SOIL STRUCTURE INTERACTIONS; ULSI CIRCUITS;

ENDOTHELIAL CELLS;

AMYLOID PRECURSOR PROTEIN; MATRIX METALLOPROTEINASE 14; PHTHALIMIDE DERIVATIVE; PHTHALIMIDE NEOVASCULAR FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CELL STIMULATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; FLUORESCENCE ANALYSIS; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROARRAY ANALYSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VALIDATION STUDY;

CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME INHIBITORS; GENE EXPRESSION PROFILING; HUMANS; INDOLES; MATRIX METALLOPROTEINASE 14; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN CULTURE TECHNIQUES;

EID: 67650133254     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.22310     Document Type: Article

References (59)

1. Anderson CR, Hastings NE, Blackman BR, Price RJ. 2008. Capillary sprout endothelial cells exhibit a CD36 low phenotype: Regulation by shear stress and vascular endothelial growth factor-induced mechanism for attenuating anti-proliferative thrombospondin-1 signaling. Am J Pathol 173(4):1220-1228.
2. Bayless KJ, Davis GE. 2003. Sphingosine-1-phosphate markedly induces matrix metalloproteinase and integrin-dependent human endothelial cell invasion and lumen formation in three-dimensional collagen and fibrin matrices. Biochem Biophys Res Commun 312(4):903-913. (Pubitemid 37490902)
3. Berglund JD, Galis ZS. 2003. Designer blood vessels and therapeutic revascularization. Br J Pharmacol 140(4):627-636. (Pubitemid 37390847)
4. Bernas GC. 2003. Angiotherapeutics from natural products: From bench to clinics? Clin Hemorheol Microcirc 29(3-4):199-203.
5. Boscolo E, Folin M, Nico B, Grandi C, Mangieri D, Longo V, Scienza R, Zampieri P, Conconi MT, Parnigotto PP, Ribatti D. 2007. Beta amyloid angiogenic activity in vitro and in vivo. Int J Mol Med 19(4):581-587.
6. Brey EM, Uriel S, Greisler HP, McIntire LV. 2005. Therapeutic neovascularization: Contributions from bioengineering. Tissue Eng 11(3-4): 567-584.
7. Bryant M, Drew GM, Houston P, Hissey P, Campbell CJ, Braddock M. 2000. Tissue repair with a therapeutic transcription factor. Hum Gene Ther 11(15):2143-2158. (Pubitemid 30778416)
8. Cheng S, Lovett DH. 2003. Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. Am J Pathol 162(6):1937-1949. (Pubitemid 36613051)
9. Chipuk JE, Cornelius SC, Pultz NJ, Jorgensen JS, Bonham MJ, Kim SJ, Danielpour D. 2002. The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3. J Biol Chem 277(2):1240-1248. (Pubitemid 34968875)
10. Chun TH, Sabeh F, Ota I, Murphy H, McDonagh KT, Holmbeck K, Birkedal-Hansen H, Allen ED, Weiss SJ. 2004. MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J Cell Biol 167(4):757-767. (Pubitemid 39565155)
11. D'Amato RJ, Loughnan MS, Flynn E, Folkman J. 1994. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91(9):4082-4085.
12. Essner JJ, Chen E, Ekker SC. 2006. Syndecan-2. Int J Biochem Cell Biol 38(2):152-156.
13. Fahmy RG, Dass CR, Sun LQ, Chesterman CN, Khachigian LM. 2003. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat Med 9(8):1026-1032. (Pubitemid 37021782)
14. Freedman SB, Isner JM. 2002. Therapeutic angiogenesis for coronary artery disease. Ann Intern Med 136(1):54-71. (Pubitemid 34038697)
15. Golubkov VS, Chekanov AV, Shiryaev SA, Aleshin AE, Ratnikov BI, Gawlik K, Radichev I, Motamedchaboki K, Smith JW, Strongin AY. 2007. Proteolysis of the membrane type-1 matrix metalloproteinase prodomain: Implications for a two-step proteolytic processing and activation. J Biol Chem 282(50):36283-36291.
16. Gullestad L, Ueland T, Fjeld JG, Holt E, Gundersen T, Breivik K, Folling M, Hodt A, Skardal R, Kjekshus J, Andreassen A, Kjekshus E, Wergeland R, Yndestad A, Frøland SS, Semb AG, Aukrust P. 2005. Effect of thalidomide on cardiac remodeling in chronic heart failure: Results of a double-blind, placebo-controlled study. Circulation 112(22):3408-3414. (Pubitemid 43739555)
17. Haas TL. 2005. Endothelial cell regulation of matrix metalloproteinases. Can J Physiol Pharmacol 83(1):1-7. (Pubitemid 40754769)
18. Haas TL, Madri JA. 1999. Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: Implications for angiogenesis. Trends Cardiovasc Med 9(3-4):70-77. (Pubitemid 29512239)
19. Haas TL, Davis SJ, Madri JA. 1998. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J Biol Chem 273(6):3604-3610. (Pubitemid 28109785)
20. Harris-White ME, Chu T, Balverde Z, Sigel JJ, Flanders KC, Frautschy SA. 1998. Effects of transforming growth factor-beta (isoforms 1-3) on amyloid-beta deposition, inflammation, and cell targeting in organotypic hippocampal slice cultures. J Neurosci 18(24):10366-10374. (Pubitemid 29016556)
21. Hastings NE, Simmers MB, McDonald OG, Wamhoff BR, Blackman BR. 2007. Atherosclerosis-prone hemodynamics differentially regulates endothelial and smooth muscle cell phenotypes and promotes proinflammatory priming. Am J Physiol Cell Physiol 293(6):C1824-C1833. (Pubitemid 350255075)
22. Heissig B, Hattori K, Friedrich M, Rafii S, Werb Z. 2003. Angiogenesis: Vascular remodeling of the extracellular matrix involves metalloproteinases. Curr Opin Hematol 10(2):136-141. (Pubitemid 36207969)
23. Hiraoka N, Allen E, Apel IJ, Gyetko MR, Weiss SJ. 1998. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95(3):365-377. (Pubitemid 28507325)
24. Hockel M, Schlenger K, Doctrow S, Kissel T, Vaupel P. 1993. Therapeutic angiogenesis. Arch Surg 128(4):423-429.
25. Hotary K, Allen E, Punturieri A, Yana I, Weiss SJ. 2000. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2 and 3. J Cell Biol 149(6):1309-1323. (Pubitemid 30399683)
26. Hughes GC, Biswas SS, Yin B, Coleman RE, DeGrado TR, Landolfo CK, Lowe JE, Annex BH, Landolfo KP. 2004. Therapeutic angiogenesis in chronically ischemic porcine myocardium: Comparative effects of bFGF and VEGF. Ann Thorac Surg 77(3):812-818. (Pubitemid 38292073)
27. Ichioka S, Minh TC, Shibata M, Nakatsuka T, Sekiya N, Ando J, Harii K. 2002. In vivo model for visualizing flap microcirculation of ischemiareperfusion. Microsurgery 22(7):304-310.
28. Itoh Y, Seiki M. 2006. MT1-MMP: A potent modifier of pericellular microenvironment. J Cell Physiol 206(1):1-8. (Pubitemid 41740711)
29. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S. 1998. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 58(5):1048-1051. (Pubitemid 28182477)
30. Itoh Y, Ito N, Nagase H, Evans RD, Bird SA, Seiki M. 2006. Cell surface collagenolysis requires homodimerization of the membrane-bound collagenase MT1-MMP. Mol Biol Cell 17(12):5390-5399. (Pubitemid 44907378)
31. Johnson PC, Mikos AG, Fisher JP, Jansen JA. 2007. Strategic directions in tissue engineering. Tissue Eng 13(12):2827-2837.
32. Josko J, Mazurek M. 2004. Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. Med Sci Monit 10(4):RA89-RA98. (Pubitemid 38525095)
33. Lee YS, Jang HS, Kim JM, Lee JS, Lee JY, Li Kim K, Shin IS, Suh W, Choi JH, Jeon ES, Byun J, Kim DK. 2005. Adenoviral-mediated delivery of early growth response factor-1 gene increases tissue perfusion in a murine model of hindlimb ischemia. Mol Ther 12(2):328-336. (Pubitemid 41025104)
34. Lehr HA, Leunig M, Menger MD, Nolte D, Messmer K. 1993. Dorsal skinfold chamber technique for intravital microscopy in nude mice. Am J Pathol 143(4):1055-1062. (Pubitemid 24070548)
35. Li C, Wong WH. 2001. Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection. Proc Natl Acad Sci USA 98(1):31-36. (Pubitemid 32095858)
36. Madeddu P. 2005. Therapeutic angiogenesis and vasculogenesis for tissue regeneration. Exp Physiol 90(3):315-326. (Pubitemid 40685844)
37. Neth P, Ries C, Karow M, Egea V, Ilmer M, Jochum M. 2007. The Wnt signal transduction pathway in stem cells and cancer cells: Influence on cellular invasion. Stem Cell Rev 3(1):18-29. (Pubitemid 47484973)
38. Neumann U, Kubota H, Frei K, Ganu V, Leppert D. 2004. Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme. Anal Biochem 328(2):166-173. (Pubitemid 38542933)
39. Nickerson MM, Song J, Shuptrine CW, Wieghaus KA, Botchwey EA, Price RJ. 2008. Influence of poly(D,L-lactic-co-glycolic acid) microsphere degradation on arteriolar remodeling in the mouse dorsal skinfold window chamber. J Biomed Mater Res. DOI:10.1002/jbm.a.32209
40. Nicosia RF, Bonanno E, Smith M. 1993. Fibronectin promotes the elongation of microvessels during angiogenesis in vitro. J Cell Physiol 154(3): 654-661. (Pubitemid 23076335)
41. Ono M, Kuwano M. 2006. Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugs. Clin Cancer Res 12(24):7242-7251. (Pubitemid 46095395)
42. Overall CM, Kleifeld O. 2006. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 6(3):227-239.
43. Penault-Llorca F, Bibeau F, Arnould L, Bralet MP, Rochaix P, Sabourin JC. 2005. EGFR expression in colorectal cancer and role in tumorigenesis. Bull Cancer 92(Spec no.):S5-S11. (Pubitemid 43046493)
44. Pepper MS. 2001. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 21(7):1104-1117. (Pubitemid 34215137)
45. Rucker M, Laschke MW, Junker D, Carvalho C, Schramm A, Mulhaupt R, Gellrich NC, Menger MD. 2006. Angiogenic and inflammatory response to biodegradable scaffolds in dorsal skinfold chambers of mice. Biomaterials 27(29):5027-5038. (Pubitemid 43949420)
46. Sithu SD, English WR, Olson P, Krubasik D, Baker AH, Murphy G, D'Souza SE. 2007. Membrane-type 1-matrix metalloproteinase regulates intracellular adhesion molecule-1 (ICAM-1)-mediated monocyte transmigration. J Biol Chem 282(34):25010-25019. (Pubitemid 47347548)
47. Sodek KL, Ringuette MJ, Brown TJ. 2007. MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells. Br J Cancer 97(3):358-367. (Pubitemid 47196736)
48. Stetler-Stevenson WG. 1999. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention. J Clin Invest 103(9):1237-1241. (Pubitemid 29218293)
49. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM. 1994. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 93(2):662-670. (Pubitemid 24072807)
50. Timur AA, Driscoll DJ, Wang Q. 2005. Biomedicine and diseases: The Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesis. Cell Mol Life Sci 62(13):1434-1447. (Pubitemid 40922947)
51. van Hinsbergh VW, Koolwijk P. 2008. Endothelial sprouting and angiogenesis: Matrix metalloproteinases in the lead. Cardiovasc Res 78(2):203-212. (Pubitemid 351556093)
52. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z. 1998. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93(3):411-422. (Pubitemid 28232085)
53. Wieghaus KA, Capitosti SM, Brown ML, Botchwey EA. 2005. Novel angiogenic compounds for targeted drug delivery. In: Laurencin CT, Botchwey EA, editors. Nanoscale materials science in biology and medicine. Warrendale, PA: Materials Research Society, p 357-361.
54. Wieghaus KA, Capitosti SM, Anderson CR, Price RJ, Blackman BR, Brown ML, Botchwey EA. 2006. Small molecule inducers of angiogenesis for tissue engineering. Tissue Eng 12(7):1903-1913. (Pubitemid 44162849)
55. Wieghaus KA, Gianchandani EP, Brown ML, Papin JA, Botchwey EA. 2007. Mechanistic exploration of phthalimide neovascular factor 1 using network analysis tools. Tissue Eng 13(10):2561-2575. (Pubitemid 47571694)
56. Wieghaus KA, Gianchandani EP, Paige MA, Brown ML, Botchwey EA, Papin JA. 2008a. Novel pathway compendium analysis elucidates mechanismof pro-angiogenic synthetic small molecule. Bioinformatics 24(20):2384-2390.
57. Wieghaus KA, Nickerson MM, Petrie Aronin CE, Sefcik LS, Price RJ, Paige MA, Brown ML, Botchwey EA. 2008b. Expansion of microvascular networks in vivo by phthalimide neovascular factor 1 (PNF1). Biomaterials 29(35):4698-4708.
58. Will H, Atkinson SJ, Butler GS, Smith B, Murphy G. 1996. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem 271(29):17119-17123. (Pubitemid 26244261)
59. Wolf K, Wu YI, Liu Y, Geiger J, Tam E, Overall C, Stack MS, Friedl P. 2007. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol 9(8):893-904. (Pubitemid 47190444)